(Updated - October 9, 2024 6:10 AM EDT)

Oppenheimer analyst Leland Gershell raised the price target on Immunovant (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE